Genzyme News
Most Popular Genzyme Story
The world's most expensive drugs
Genzyme drugs take four spots among the most expensive in a Forbes survey (chart). The developer's rare disease treatments Myozyme, Fabrazyme, Cerezyme and Aldurazyme all cost over $200,000 per year.... Read more...
Latest Headlines
- March 2, 2010
- February 24, 2010
- February 17, 2010
- January 5, 2010
- November 17, 2009
- November 11, 2009
- November 10, 2009
- November 4, 2009
- September 28, 2009
- September 15, 2009
- September 1, 2009
- August 12, 2009
- August 3, 2009
- June 29, 2009
- June 24, 2009
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
